These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

706 related items for PubMed ID: 24976430

  • 1. Effect of vitamin E supplementation on aminotransferase levels in patients with NAFLD, NASH, and CHC: results from a meta-analysis.
    Ji HF, Sun Y, Shen L.
    Nutrition; 2014 Sep; 30(9):986-91. PubMed ID: 24976430
    [Abstract] [Full Text] [Related]

  • 2. Vitamin E has a beneficial effect on nonalcoholic fatty liver disease: a meta-analysis of randomized controlled trials.
    Sato K, Gosho M, Yamamoto T, Kobayashi Y, Ishii N, Ohashi T, Nakade Y, Ito K, Fukuzawa Y, Yoneda M.
    Nutrition; 2015 Sep; 31(7-8):923-30. PubMed ID: 26059365
    [Abstract] [Full Text] [Related]

  • 3. Vitamin E therapy on aminotransferase levels in NAFLD/NASH patients.
    Ji HF.
    Nutrition; 2015 Jun; 31(6):899. PubMed ID: 25933502
    [No Abstract] [Full Text] [Related]

  • 4. Vitamin E therapy for NAFLD/NASH.
    Yoneda M, Hasegawa T, Sato K.
    Nutrition; 2015 Jun; 31(6):898-9. PubMed ID: 25933501
    [No Abstract] [Full Text] [Related]

  • 5. Systematic review with meta-analysis: The effect of vitamin E supplementation in adult patients with non-alcoholic fatty liver disease.
    Vadarlis A, Antza C, Bakaloudi DR, Doundoulakis I, Kalopitas G, Samara M, Dardavessis T, Maris T, Chourdakis M.
    J Gastroenterol Hepatol; 2021 Feb; 36(2):311-319. PubMed ID: 32810309
    [Abstract] [Full Text] [Related]

  • 6. Does turmeric/curcumin supplementation improve serum alanine aminotransferase and aspartate aminotransferase levels in patients with nonalcoholic fatty liver disease? A systematic review and meta-analysis of randomized controlled trials.
    Goodarzi R, Sabzian K, Shishehbor F, Mansoori A.
    Phytother Res; 2019 Mar; 33(3):561-570. PubMed ID: 30653773
    [Abstract] [Full Text] [Related]

  • 7. The Effect of Vitamin E Supplementation on Serum Aminotransferases in Non-Alcoholic Fatty Liver Disease (NAFLD): A Systematic Review and Meta-Analysis.
    Vogli S, Naska A, Marinos G, Kasdagli MI, Orfanos P.
    Nutrients; 2023 Aug 25; 15(17):. PubMed ID: 37686767
    [Abstract] [Full Text] [Related]

  • 8. The role of liver fat and insulin resistance as determinants of plasma aminotransferase elevation in nonalcoholic fatty liver disease.
    Maximos M, Bril F, Portillo Sanchez P, Lomonaco R, Orsak B, Biernacki D, Suman A, Weber M, Cusi K.
    Hepatology; 2015 Jan 25; 61(1):153-60. PubMed ID: 25145475
    [Abstract] [Full Text] [Related]

  • 9. The ratio of aspartate aminotransferase to alanine aminotransferase: potential value in differentiating nonalcoholic steatohepatitis from alcoholic liver disease.
    Sorbi D, Boynton J, Lindor KD.
    Am J Gastroenterol; 1999 Apr 25; 94(4):1018-22. PubMed ID: 10201476
    [Abstract] [Full Text] [Related]

  • 10. Acetyl-L-carnitine and lipoic acid improve mitochondrial abnormalities and serum levels of liver enzymes in a mouse model of nonalcoholic fatty liver disease.
    Kathirvel E, Morgan K, French SW, Morgan TR.
    Nutr Res; 2013 Nov 25; 33(11):932-41. PubMed ID: 24176233
    [Abstract] [Full Text] [Related]

  • 11. Vitamin D and non-alcoholic fatty liver disease: a meta-analysis of randomized controlled trials.
    Guo XF, Wang C, Yang T, Li S, Li KL, Li D.
    Food Funct; 2020 Sep 23; 11(9):7389-7399. PubMed ID: 32966467
    [Abstract] [Full Text] [Related]

  • 12. Current pharmacological therapies for nonalcoholic fatty liver disease/nonalcoholic steatohepatitis.
    Takahashi Y, Sugimoto K, Inui H, Fukusato T.
    World J Gastroenterol; 2015 Apr 07; 21(13):3777-85. PubMed ID: 25852263
    [Abstract] [Full Text] [Related]

  • 13. Comparative effects of thymol and vitamin E on nonalcoholic fatty liver disease in male Wistar rats.
    Lahmi A, Oryan S, Eidi A, Rohani AH.
    Braz J Biol; 2023 Apr 07; 84():e268781. PubMed ID: 36629640
    [Abstract] [Full Text] [Related]

  • 14. The pilot study of 3-month course of melatonin treatment of patients with nonalcoholic steatohepatitis: effect on plasma levels of liver enzymes, lipids and melatonin.
    Gonciarz M, Gonciarz Z, Bielanski W, Mularczyk A, Konturek PC, Brzozowski T, Konturek SJ.
    J Physiol Pharmacol; 2010 Dec 07; 61(6):705-10. PubMed ID: 21224501
    [Abstract] [Full Text] [Related]

  • 15. Combination of Aspartate Aminotranferase and Tumor Necrosis Factor-α as Non Invasive Diagnostic Tools for Non Alcoholic Steatohepatitis (NASH).
    Purnomo HD, Mundhofir FE, Kasno, Sudijanto E, Darmono, Daldiyono, Djokomoeljanto R, Faradz SM.
    Acta Med Indones; 2015 Jan 07; 47(1):16-23. PubMed ID: 25948763
    [Abstract] [Full Text] [Related]

  • 16. [Clinical and histological features of non-alcoholic fatty liver disease].
    Shi JP, Xun YH, Hu CB, Zhang L, Liu H, Lou GQ, Fan JG.
    Zhonghua Gan Zang Bing Za Zhi; 2009 Nov 07; 17(11):812-6. PubMed ID: 19958638
    [Abstract] [Full Text] [Related]

  • 17. Prevalence and associated metabolic factors of fatty liver disease in the elderly.
    Wang Z, Xu M, Peng J, Jiang L, Hu Z, Wang H, Zhou S, Zhou R, Hultström M, Lai EY.
    Exp Gerontol; 2013 Aug 07; 48(8):705-9. PubMed ID: 23721951
    [Abstract] [Full Text] [Related]

  • 18. Vitamin E and nonalcoholic fatty liver disease.
    Pacana T, Sanyal AJ.
    Curr Opin Clin Nutr Metab Care; 2012 Nov 07; 15(6):641-8. PubMed ID: 23075940
    [Abstract] [Full Text] [Related]

  • 19. The effects of resveratrol supplementation on cardiovascular risk factors in patients with non-alcoholic fatty liver disease: a randomised, double-blind, placebo-controlled study.
    Faghihzadeh F, Adibi P, Hekmatdoost A.
    Br J Nutr; 2015 Sep 14; 114(5):796-803. PubMed ID: 26234526
    [Abstract] [Full Text] [Related]

  • 20. Vitamin E supplementation in the treatment on nonalcoholic fatty liver disease (NAFLD): Evidence from an umbrella review of meta-analysis on randomized controlled trials.
    Wang MY, Prabahar K, Găman MA, Zhang JL.
    J Dig Dis; 2023 Sep 14; 24(6-7):380-389. PubMed ID: 37503812
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 36.